Biopharma Plazma LLC (manufacturing, primary and secondary packaging, quality control, batch release)
UkraineAll drugs from this manufacturer
-
The drug is used to restore and maintain blood circulation volume in cases of volume deficit where the use of colloids is required.
Dosage form: solution for infusion
Active substance Dosage human albumin 100 g/L ATC: B05AA01
-
The drug is used to restore and maintain blood circulation volume in cases of volume deficit where the use of colloids is required.
Dosage form: solution for infusion
Active substance Dosage human albumin 200 g/l ATC: B05AA01
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency), as well as for the correction of acquired factor VIII deficiency. It is also used for the prevention and treatment of bleeding in von Willebrand disease if desmopressin treatment is ineffective or contraindicated.
Dosage form: lyophilisate for solution for injection
Active substance Dosage human coagulation factor viii 500 IU human von willebrand factor 250 IU ATC: B02BD06
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A, as well as for the correction of acquired factor VIII deficiency. It is also used for the prevention and treatment of bleeding in von Willebrand disease if desmopressin is ineffective or contraindicated.
Dosage form: lyophilisate for solution for injection
Active substance Dosage human coagulation factor viii 250 IU human von willebrand factor 125 IU ATC: B02BD06
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A, as well as for the correction of acquired factor VIII deficiency. It is also used for the treatment or prevention of bleeding in von Willebrand disease if desmopressin is ineffective or contraindicated.
Dosage form: lyophilisate for solution for injection
Active substance Dosage human coagulation factor viii 1000 IU human von willebrand factor 500 IU ATC: B02BD06
-
The drug is used for replacement therapy in primary and secondary immunodeficiencies, as well as for the treatment of severe bacterial and viral infections. It is also used for immunomodulation in conditions such as Guillain-Barré syndrome, Kawasaki disease, primary immune thrombocytopenia, and certain autoimmune diseases.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 50 mg/ml ATC: J06BA02
-
The drug is used for replacement immunotherapy in primary and secondary immunodeficiency states (e.g., in congenital agammaglobulinemia or severe infections). It is also used in certain autoimmune diseases (e.g., Guillain-Barré syndrome, idiopathic thrombocytopenic purpura) and as part of complex therapy for adults with severe pneumonia caused by COVID-19.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 0.1 g/ml ATC: J06BA02